NEU 0.00% $17.09 neuren pharmaceuticals limited

Indeed ... and I suspect his broken sentence suggests that he...

  1. 264 Posts.
    lightbulb Created with Sketch. 22
    Indeed ... and I suspect his broken sentence suggests that he didn't want to even hint that 2591 is probably a 'better' therapy prospect in Rett (and Fragile X) than Daybue, ... needing to wring the most out of trofinitide/Daybue before focusing on 2591.
    Last edited by comora: 20/03/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.